PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells

Por Soliman, Hatem, Khalil, Farah, Antonia, Scott
Publicado em 2014

Indoleamine 2,3-Dioxygenase: Is It an Immune Suppressor?

Por Soliman, Hatem, Mediavilla-Varela, Melanie, Antonia, Scott
Publicado em 2010

A new role for NFκB in immunosurveillance and its implications for cancer immunotherapy

Por Beg, Amer A, Khan, Tahira, Antonia, Scott J
Publicado em 2013

A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model

Por Soliman, Hatem, Mediavilla-Varela, Melanie, Antonia, Scott J
Publicado no Breast Cancer (Dove Med Press) (2015)

Thymidylate Synthase 1 (TS1) in Situ Protein Expression Predicts the Survival of Ewing/PNET

Por Bui, Marilyn M., Zheng, Zhong, Antonia, Scott, Bepler, Gerold
Publicado em 2010

CANCER IMMUNOLOGY AT THE CROSSROADS: FUNCTIONAL PROTEOMICS: Charting immune signaling proteomes en route to new therapeutic strategies

Por Haura, Eric B., Beg, Amer A., Rix, Uwe, Antonia, Scott
Publicado no Cancer Immunol Res (2015)

The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts

Por Mediavilla-Varela, Melanie, Boateng, Kingsley, Noyes, David, Antonia, Scott J.
Publicado no BMC Cancer (2016)

Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer

Por Iclozan, Cristina, Antonia, Scott, Chiappori, Alberto, Chen, Dung-Tsa, Gabrilovich, Dmitry
Publicado em 2013

Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors

Por Rüter, Jens, Antonia, Scott J, Burris, Howard A, Huhn, Richard D, Vonderheide, Robert H
Publicado em 2010

INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect

Por Chiappori, Alberto A, Soliman, Hatem, Janssen, William E, Antonia, Scott J, Gabrilovich, Dmitry I
Publicado em 2010

Paclitaxel and TRAIL Synergize to Kill Paclitaxel-resistant Small Cell Lung Cancer Cells through a Caspase-independent Mechanism Mediated through AIF

Por HUNTER, TERRI B., MANIMALA, NEIL J., LUDDY, KIMBERLY A., CATLIN, TRACY, ANTONIA, SCOTT J.
Publicado no Anticancer Res (2011)

Cellular immunotherapy for soft tissue sarcomas

Por Finkelstein, Steven Eric, Fishman, Mayer, Conley, Anthony P., Gabrilovich, Dmitry, Antonia, Scott, Chiappori, Alberto
Publicado no Immunotherapy (2012)

Non–Small Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy

Por Carbone, David P., Gandara, David R., Antonia, Scott J., Zielinski, Christoph, Paz-Ares, Luis
Publicado no J Thorac Oncol (2015)

The Bottleneck Effect in Lung Cancer Clinical Trials

Por Gonzalez, Luis E., Sutton, Steven K., Pratt, Christie, Gilbertson, Matthew, Antonia, Scott, Quinn, Gwendolyn P.
Publicado no J Cancer Educ (2013)

Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer

Por Creelan, Ben C., Antonia, Scott, Bepler, Gerold, Garrett, Timothy J., Simon, George R., Soliman, Hatem H.
Publicado em 2013

Early indication of survival benefit from ERCC1 and RRM1 tailored chemotherapy in patients with advanced Non-Small Cell Lung Cancer (NSCLC). Evidence from an individual patient ana...

Por Simon, George R., Schell, Michael J., Begum, Mubeena, Kim, Jongphil, Chiappori, Alberto, Haura, Eric, Antonia, Scott, Bepler, Gerold
Publicado em 2011

Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth

Por Mediavilla-Varela, Melanie, Luddy, Kimberly, Noyes, David, Khalil, Farah K, Neuger, Anthony M, Soliman, Hatem, Antonia, Scott J
Publicado em 2013

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

Por Ramakrishnan, Rupal, Assudani, Deepak, Nagaraj, Srinivas, Hunter, Terri, Cho, Hyun-Il, Antonia, Scott, Altiok, Soner, Celis, Esteban, Gabrilovich, Dmitry I.
Publicado em 2010

Development of MEDI4736, an anti-programmed cell death ligand 1 (PD-L1) antibody, as monotherapy or in combination with other therapies in the treatment of non-small cell lung canc...

Por Brahmer, Julie, Balmanoukian, Ani, Goldberg, Sarah, Ou, Sai-Hong, Blake-Haskins, Andrew, Karakunnel, Joyson, Stockman, Paul, Rizvi, Naiyer, Antonia, Scott
Publicado no J Immunother Cancer (2014)

Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung

Por Robinson, Lary A, Jaing, Crystal J, Pierce Campbell, Christine, Magliocco, Anthony, Xiong, Yin, Magliocco, Genevra, Thissen, James B, Antonia, Scott
Publicado no Br J Cancer (2016)